Managers / Q3 2023 · view latest →
NVP Associates, LLC
CIK 0001545692 · 1300 EL CAMINO REAL, SUITE 200, MENLO PARK, CA, 94025 · 650-321-8000
Summary
Nvp Associates, LLC reported $112M in U.S.-listed holdings across 8 positions for Q3 2023.
The portfolio is heavily concentrated: 7WH alone accounts for 53.0% of reported value.
Compared with Q2 2023, the fund opened 1 new position and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 100.0% · $112M
- Other · 0.0% · $23,446
Quarter-over-Quarter Changes full breakdown →
vs Q2 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| DIGITAL BRANDS GROUP INC | NEW | +636 | 636 | +$5,361 | $5,361 |
| SNAPSNAP INC | SOLD OUT | −3.5K | 0 | −$40,978 | $0 |
| DIGITAL BRANDS GROUP INC | SOLD OUT | −15.9K | 0 | −$10,487 | $0 |
| TALKTALKSPACE INC | HELD | +0 | 14.70M | +$10M | $29M |
| 7WHUDEMY INC | HELD | +0 | 6.23M | −$8M | $59M |
| OPENOPENDOOR TECHNOLOGIES INC | HELD | +0 | 4.19M | −$6M | $11M |
| GROVGROVE COLLABORATIVE HOLD INC | HELD | +0 | 2.94M | +$3M | $8M |
| IMPEL PHARMACEUTICALS INC | HELD | +0 | 3.08M | −$3M | $1M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2023
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | 7WHUDEMY INChistory → | COM | 52.98% | $59M | 6.23M |
| 2 | TALKTALKSPACE INChistory → | COM | 25.67% | $29M | 14.70M |
| 3 | OPENOPENDOOR TECHNOLOGIES INChistory → | COM | 9.90% | $11M | 4.19M |
| 4 | GROVGROVE COLLABORATIVE HOLD INChistory → | COM CL A | 7.01% | $8M | 2.94M |
| 5 | DAVEDAVE INChistory → | CLASS A COM NEW | 3.23% | $4M | 582.7K |
| 6 | IMPEL PHARMACEUTICALS INC | COM | 1.18% | $1M | 3.08M |
| 7 | BORQS TECHNOLOGIES INC | SHS NEW | 0.02% | $18,085 | 101.1K |
| 8 | DIGITAL BRANDS GROUP INC | COM NEW | 0.00% | $5,361 | 636 |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $176M | 5 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $255M | 6 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $166M | 5 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $184M | 7 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $112M | 6 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $187M | 7 | Feb 10, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $176M | 8 | Nov 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $91M | 6 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $126M | 6 | May 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $112M | 6 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $112M | 8 | Nov 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $115M | 9 | Aug 1, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $87M | 8 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $102M | 8 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.